Harry Palmin

Opexa Therapeutics

Chief Operating Officer and Chief Financial Officer

Overview

Harry Palmin made an average of $561.3K in compensation at Opexa Therapeutics between 2017 and 2018.

Annual data

2018

In 2018, Harry Palmin earned a total compensation of $429.3K as Chief Operating Officer and Chief Financial Officer at Opexa Therapeutics.

Ranking9,796 out of 10,998
Percentile10.9%

Harry Palmin's 2018 compensation ranked 9,796th out of 10,998 executive pay records tracked by us this year.

Palmin earned more than 10.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,178 out of 1,265
Percentile6.9%

In the industry group of Drugs, Palmin's pay ranked 1,178th out of 1,265 executive pay records tracked by us in 2018.

Palmin earned more than 6.9% of executives in this group.

Bonus$89,250
Salary$340,000
Total$429,250

Palmin received $340K in salary, which accounts for 79.21% of total compensation.

Palmin also received $89.3K in bonus.

2017

In 2017, Harry Palmin earned a total compensation of $693.3K as Chief Financial Officer at Opexa Therapeutics.

Ranking10,057 out of 13,798
Percentile27.1%

Harry Palmin's 2017 compensation ranked 10,057th out of 13,798 executive pay records tracked by us this year.

Palmin earned more than 27.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,119 out of 1,568
Percentile28.6%

In the industry group of Drugs, Palmin's pay ranked 1,119th out of 1,568 executive pay records tracked by us in 2017.

Palmin earned more than 28.6% of executives in this group.

Option Awards$594,151
Salary$99,167
Total$693,318

Palmin received $594.2K in option awards, which accounts for 85.70% of total compensation.

Palmin also received $99.2K in salary.